Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-27.05	69.84	95.73
Graham Fair Price	-37.41	0.72	1.16
PEG	-23.65	-1.29	-1.05
Price/Book	-54.17	2.32	5.06
Price/Cash Flow	-79.32	-69.21	334.59
Prices/Earnings	20.82	79.63	65.90
Price/Sales	-43.79	15.19	27.03
Price/FCF	-79.32	-69.21	334.59
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-9.82	0.49	0.54
Operating Margin	-53.92	0.08	0.16
ROA	-59.75	< 0.005	0.01
ROE	0.02	< 0.005	-62.07
ROIC	0.02	< 0.005	-64.23
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.03	-0.03	-1.55
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.54	-0.62	-14.05
EPS QOQ	-0.63	-0.62	2.29
FCF QOQ	2.64	-3.25	23.26
Revenue QOQ	-0.16	-0.17	-7.44
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-3.28	-3.47	-5.57
Days Sales Outstanding (DSO)	24.52	22.66	-7.57
Inventory Turnover	-27.41	-25.96	5.28
Debt/Capitalization	0.20	0.20	-3.72
Quick Ratio	2.98	2.19	-26.58
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.76	1.79	1.63
Cash	0.53	0.45	-14.15
Capex	-0.12	-0.16	-28.96
Free Cash Flow	0.03	-0.06	125.18
Revenue	0.33	0.27	-17.13
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.07	2.27	-26.18
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.44	0.33	-25.17
Naive Interpretation	Member

06 - Financial Health · Bad

Rating